Quetiapine and QTc issues: A case report [5]

Journal of Clinical Psychiatry

Volumn 64, Issue 5, 2003, Pages 612-613

  Gupta, Sanjay ^a   Nienhaus, Kristin ^b   Shah, Syed A ^a  

^a Olean General Hospital   (United States)

^b DAEMEN COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUPHENAZINE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; QUETIAPINE;

ADULT; AUDITORY HALLUCINATION; CASE REPORT; DISEASE COURSE; DRUG DOSE REDUCTION; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LETTER; LONG QT SYNDROME; MORBID OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS;

EID: 0038486213     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0518e     Document Type: Letter

References (6)

1. Glassman AH, Bigger JT Jr. Antipsychotic drugs: prolonged QTc interval, torsades de pointes, and sudden death. Am J Psychiatry 2001;158:1774-1782
2. Gupta S, Masand PS, Kothari AJ. Cardiovascular side-effects of novel antipsychotics. CNS Spectrums 2001;6:912-918
3. Beelan AP, Yeo KT, Lewis LD. Asymptomatic QTc prolongation associated with quetiapine fumarate overdose in a patient being treated with risperidone. Hum Exp Toxicol 2001;20:215-219
4. Gajwani P, Pozudo L, Tesar GE. QT interval prolongation associated with quetiapine (Seroquel) overdose. Psychosomatics 2000;41:63-65
5. Pfizer Inc. Study Repon of Ziprasidone Clinical Pharmacology Protocol. Rockville, Md: FDA Center for Drug Evaluation and Research Division of Cardiorenal Dmg Products Consultation; 2000
6. Justice JD, Thistlethwaite DB, Voltin RI, et al. Two cases of QTc prolongation with ziprasidone in the elderly. Presented at the 53rd annual meeting of the Institute on Psychiatric Services; Oct 10-14, 2001; Orlando, Fla